Editas Medicine
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell EDIT and other ETFs, options, and stocks.About EDIT
Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9).
CEOGilmore O’Neill
CEOGilmore O’Neill
Employees246
Employees246
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2013
Founded2013
Employees246
Employees246
EDIT Key Statistics
Market cap137.70M
Market cap137.70M
Price-Earnings ratio-0.54
Price-Earnings ratio-0.54
Dividend yield—
Dividend yield—
Average volume1.65M
Average volume1.65M
High today$1.65
High today$1.65
Low today$1.45
Low today$1.45
Open price$1.52
Open price$1.52
Volume1.13M
Volume1.13M
52 Week high$6.69
52 Week high$6.69
52 Week low$0.9101
52 Week low$0.9101
EDIT News
Simply Wall St 4d
Recent uptick might appease Editas Medicine, Inc. institutional owners after losing 71% over the past yearAdvertisement Key Insights Significantly high institutional ownership implies Editas Medicine's stock price is sensitive to their trading actions 50% of the...
TipRanks 5d
Biotech Alert: Searches spiking for these stocks todayThese names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Pipeline and key...
Analyst ratings
47%
of 15 ratingsBuy
40%
Hold
46.7%
Sell
13.3%
People also own
Based on the portfolios of people who own EDIT. This list is generated using Robinhood data, and it’s not a recommendation.